Abstract / Summary
Vitamin D deficiency has been proposed as a potential contributor to insulin resistance (IR) in polycystic ovary syndrome (PCOS); however, the evidence remains inconclusive. This meta-analysis evaluated the association between serum 25-hydroxyvitamin D [25(OH)D] and IR in PCOS. We systematically searched PubMed, Embase, Web of Science, and Cochrane Library up to December 2025 for observational studies reporting correlations of 25(OH)D with IR indices (HOMA-IR/fasting insulin) in women with PCOS. Pooled correlation coefficients (r) with 95% confidence intervals (CI) were calculated using random-effects models. Fourteen studies involving 1856 women with PCOS were included. A significant inverse correlation was found between serum 25(OH)D and IR (pooled r = -0.32, 95% CI: -0.40 to -0.23; p < 0.001; I2 = 58%). Subgroup analyses revealed stronger associations in overweight/obese women (r = -0.35) and in Asian populations (r = -0.36). Women with vitamin D deficiency (< 20 ng/mL) showed a stronger correlation (r = -0.38). Sensitivity analysis confirmed robustness, and no significant publication bias was detected. Lower serum vitamin D is significantly associated with greater insulin resistance in PCOS, especially in overweight/obese and Asian subgroups. These findings highlight the potential value of assessing vitamin D status in the metabolic evaluation of PCOS.
Primary Source
The journal of obstetrics and gynaecology research
Ask Prognia AI
Have questions about this meta-analysis?
Prognia AI can search this source alongside 35M+ PubMed papers and current ESC, AHA, NICE, and ADA guidelines to give you a fully cited clinical answer.